Trends in testosterone prescriptions for older men enrolled in commercial insurance and medicare advantage

Alexander Everhart, Katrina Harper, Molly Moore Jeffery, Zachary Levin, Nancy E. Morden, Ashwini Sankar, Pinar Karaca-Mandic

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Article numbere2127349
JournalJAMA Network Open
Volume4
Issue number9
DOIs
StatePublished - Sep 29 2021

Bibliographical note

Funding Information:
Conflict of Interest Disclosures: Mr Everhart reported receiving grants from the Agency for Healthcare Research and Quality and the National Bureau of Economic Research outside the submitted work; he reported employment with Medtronic plc during the conduct of this study. Ms Harper reported employment with Technomics Research llc outside the submitted work. Dr Jeffery reported receiving grants from the National Institutes of Health (National Heart, Lung, and Blood Institute and National Institute on Drug Abuse), the American Cancer Society, and the US Food and Drug Administration. Dr Morden reported employment with UnitedHealthcare. Dr Karaca-Mandic reported receiving grants from the National Institutes of Health/National Heart, Lung, and Blood Institute during the conduct of this study; she reported employment as cofounder of XanthosHealth, and reported receiving personal fees from Tactile Medical, Precision Health Economics, and Sempre Health outside the submitted work. No other disclosures were reported.

Funding Information:
Funding/Support: This study was funded by grant No. R01HS025164 from the Agency for Healthcare Research and Quality.

PubMed: MeSH publication types

  • Comparative Study
  • Journal Article
  • Research Support, N.I.H., Extramural

Cite this